COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds. To help keep you informed, we’re releasing a special Q&A series with our experts to discuss the virus’s impact on each stage of the development journey.
How is the COVID-19 outbreak impacting clinical trials?
There’s no avoiding it – the virus will significantly disrupt the clinical trial process at every stage. Though the extent of that disruption varies by therapeutic area, trial design, and location, these are the challenges manufacturers can expect through the key stages of a clinical trial:
How should manufacturers react?
Get on the Smartest Route to Your Pharma Product Journey with Two Labs
We Lead Pharma Manufacturers Through the Commercial Strategy and Operations Journey
We Have Deep Experience Supporting Pharma Manufacturers
New Product Launches
Years of Experience
Do you need help determining the impact of COVID-19 on your launch and how to navigate forward? Fill out the form to get in touch with our expert team.